Anticancer Activity of Bifunctional Organometallic Ru(II) Arene Complexes Containing a 7-Hydroxycoumarin Group
- 31 January 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Organometallics
- Vol. 37 (3) , 441-447
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20160664)
- National Natural Science Foundation of China (21601034)
This publication has 48 references indexed in Scilit:
- Improve the anticancer potency of the platinum(II) complexes through functionalized leaving groupJournal of Inorganic Biochemistry, 2017
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsChemical Reviews, 2016
- NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical applicationChemical Science, 2014
- The status of platinum anticancer drugs in the clinic and in clinical trialsDalton Transactions, 2010
- Metal-Based TherapeuticsScience, 2007
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Searching for the Magic Bullet: Anticancer Platinum Drugs Which Can Be Accumulated or Activated in the Tumor TissueAnti-Cancer Agents in Medicinal Chemistry, 2007
- Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexesChemical Communications, 2005
- Ruthenium Antimetastatic AgentsCurrent Topics in Medicinal Chemistry, 2004
- Ruthenium metallopharmaceuticalsCoordination Chemistry Reviews, 2003